Contineum Therapeutics, Inc. · NASDAQ:CTNM

Balyasny Asset Management L.P. reported a 7.60% stake in Contineum Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 17, 2026

Balyasny Asset Management L.P. reported a 7.60% stake in Contineum Therapeutics, Inc., 2,312,800 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).

Stake
7.60%
Shares
2,312,800
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Balyasny Asset Management L.P.7.60%2,312,800
BAM GP LLC7.60%2,312,800
Balyasny Asset Management Holdings LP7.60%2,312,800
Dames GP LLC7.60%2,312,800
Dmitry Balyasny7.60%2,312,800

Source

View original at SEC

Related